الفهرس | Only 14 pages are availabe for public view |
Abstract Coronary artery disease is the most common cause of congestive heart failure. More than70% of the patients with heart failure symptoms have underlying coronary disease, the majority of patients with ischemic cardiomyopathy have a previous myocardial infarction ( Arend F L Schinkel et al ., 2005). The aim of early treatment of acute myocardial infarction (AMI) is to achieve the rapid reperfusion of the culprit artery, which correlates with improvement in ventricular function and mortality and improved left ventricular function, a substantial number of patients still suffer from myocardial survival ( Mauro VM et al ., 2005). Although thrombolytic treatment has reduced post infarction dysfunction after acute myocardial infarction (Graham S. et al ., 2003). Determination of prognosis after survival of AMI remains a challenging clinical task. Identification of patients at high risk for a future adverse cardiac event may guide the decision for early intervention with specific myocardial medical therapy or a revascularization procedure (Michael et al ., 1997). |